CNS-3D Brain Organoids are human cortical organoids designed for predictive drug assessment. Derived from iPSC-based neural progenitor cells, they self-organize into balanced neuron–astrocyte co-cultures that form functional neural networks with spontaneous activity.

This activity is measured using calcium imaging to assess drug-induced changes in neuronal function and can be multiplexed with complementary endpoints spanning viability, imaging, and molecular analysis. CNS-3D Brain Organoids are available as assay-ready products for in-house workflows or through CNS Services for end-to-end study design, execution, and analysis.